BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83-91. [PMID: 15023176 DOI: 10.1111/j.0042-9007.2004.00406.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 183] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Mandour M, Nemr N, Shehata A, Kishk R, Badran D, Hawass N. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview. Rev Soc Bras Med Trop. 2015;48:258-264. [PMID: 26108002 DOI: 10.1590/0037-8682-0037-2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
2 Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH. Comparative analysis of triplex nucleic acid test assays in United States blood donors. Transfusion. 2013;53:2525-2537. [PMID: 23550838 DOI: 10.1111/trf.12178] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
3 Su TH, Chen PJ, Chen TC, Cheng HR, Li L, Lin KS, Kao JH, Chen DS, Liu CJ. The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study. Transfus Med. 2011;21:33-41. [PMID: 20726954 DOI: 10.1111/j.1365-3148.2010.01036.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
4 Schmidt M, Seifried E. Current concepts in serological testing - TTID: Current concepts in serological testing. ISBT Science Series 2011;6:61-6. [DOI: 10.1111/j.1751-2824.2011.01437.x] [Reference Citation Analysis]
5 Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals. Int J STD AIDS. 2009;20:336-338. [PMID: 19386971 DOI: 10.1258/ijsa.2008.008377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jang JY, Jeong SW, Cheon SR, Lee SH, Kim SG, Cheon YK, Kim YS, Cho YD, Kim HS, Jin SY. Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients. Korean J Hepatol. 2011;17:206-212. [PMID: 22102387 DOI: 10.3350/kjhep.2011.17.3.206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
7 Alzahrani FM, Muzaheed, Shaikh SS, Alomar AI, Acharya S, Elhadi N. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers. Ann Lab Med 2019;39:81-5. [PMID: 30215234 DOI: 10.3343/alm.2019.39.1.81] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz. 2006;101:655-660. [PMID: 17072479 DOI: 10.1590/s0074-02762006000600013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ye X, Li T, Shao W, Zeng J, Hong W, Lu L, Zhu W, Li C, Li T. Nearly half of Ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China. BMC Infect Dis 2019;19:574. [PMID: 31269905 DOI: 10.1186/s12879-019-4215-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Cha YJ, Yang JS, Chae SL. [Evaluation of indigenously manufactured immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody.]. Korean J Lab Med 2006;26:52-7. [PMID: 18156700 DOI: 10.3343/kjlm.2006.26.1.52] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
11 Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol. 2008;49:537-547. [PMID: 18602718 DOI: 10.1016/j.jhep.2008.04.017] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 6.1] [Reference Citation Analysis]
12 Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol. 2009;81:815-825. [PMID: 19319945 DOI: 10.1002/jmv.21499] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
13 Raimondo G, Allain J, Brunetto MR, Buendia M, Chen D, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky J, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008;49:652-7. [DOI: 10.1016/j.jhep.2008.07.014] [Cited by in Crossref: 513] [Cited by in F6Publishing: 487] [Article Influence: 39.5] [Reference Citation Analysis]
14 Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Di Marco V, Fabrizi F. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis. 2007;39:397-408. [PMID: 17382608 DOI: 10.1016/j.dld.2006.12.017] [Cited by in Crossref: 152] [Cited by in F6Publishing: 151] [Article Influence: 10.9] [Reference Citation Analysis]
15 Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008;48:1001-1026. [PMID: 18454738 DOI: 10.1111/j.1537-2995.2008.01701.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
16 Zobeiri M. Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat. 2013;2013:259148. [PMID: 23533738 DOI: 10.1155/2013/259148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
17 Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Transfus Med. 2010;20:409-413. [PMID: 20573069 DOI: 10.1111/j.1365-3148.2010.01021.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
18 Cinqualbre J, Kientz D, Remy E, Huang N, Corash L, Cazenave JP. Comparative effectiveness of plasma prepared with amotosalen-UVA pathogen inactivation and conventional plasma for support of liver transplantation. Transfusion 2015;55:1710-20. [PMID: 25857325 DOI: 10.1111/trf.13100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
19 Katz L, Strong DM, Tegtmeier G, Stramer S. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion. 2008;48:2315-2322. [PMID: 18647367 DOI: 10.1111/j.1537-2995.2008.01844.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
20 Li W, Gao Z, Yang C, Li J, Li L, Lv R, Liu Z. The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PLoS One 2013;8:e73472. [PMID: 24058476 DOI: 10.1371/journal.pone.0073472] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Allain JP, Reesink HW, Lucey C. A European perspective on the management of donors and units testing positive for hepatitis B virus DNA. Transfusion. 2006;46:1256-1258. [PMID: 16836576 DOI: 10.1111/j.1537-2995.2006.00885.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
22 Song SH, Hwang SG. [Occult hepatitis B virus infection: transmission and reactivation]. Korean J Gastroenterol 2013;62:148-53. [PMID: 24077624 DOI: 10.4166/kjg.2013.62.3.148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
23 Pondé RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709-1731. [PMID: 26105620 DOI: 10.1007/s10096-015-2422-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
24 Huang FY, Wong DK, Seto WK, Zhang AY, Lee CK, Lin CK, Fung J, Lai CL, Yuen MF. Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection. PLoS One. 2014;9:e99028. [PMID: 24901840 DOI: 10.1371/journal.pone.0099028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
25 Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol. 2008;48:1022-1025. [PMID: 18436328 DOI: 10.1016/j.jhep.2008.02.016] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
26 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
27 Palla P, Vatteroni ML, Vacri L, Maggi F, Baicchi U. HIV-1 NAT minipool during the pre-seroconversion window period: detection of a repeat blood donor. Vox Sang 2006;90:59-62. [PMID: 16359357 DOI: 10.1111/j.1423-0410.2005.00716.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
28 Domanović D, Ushiro-Lumb I, Compernolle V, Brusin S, Funk M, Gallian P, Georgsen J, Janssen M, Jimenez-Marco T, Knutson F, Liumbruno GM, Mali P, Marano G, Maryuningsih Y, Niederhauser C, Politis C, Pupella S, Rautmann G, Saadat K, Sandid I, Sousa AP, Vaglio S, Velati C, Verdun N, Vesga M, Rebulla P. Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting. Blood Transfus 2019;17:433-48. [PMID: 31846608 DOI: 10.2450/2019.0288-19] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 dos Santos Ade O, Souza LF, Borzacov LM, Villalobos-Salcedo JM, Vieira DS. Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil. Virol J. 2014;11:16. [PMID: 24472141 DOI: 10.1186/1743-422x-11-16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Pondé RA, Cardoso DD, Ferro MO. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010;155:149-58. [PMID: 20091193 DOI: 10.1007/s00705-009-0559-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
31 Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 2005;51:24-9. [PMID: 15979486 DOI: 10.1016/j.jinf.2004.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
32 Allain JP. Epidemiology of Hepatitis B virus and genotype. J Clin Virol. 2006;36 Suppl 1:S12-S17. [PMID: 16831687 DOI: 10.1016/s1386-6532(06)80003-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
33 Laperche S, Thibault V, Bouchardeau F, Alain S, Castelain S, Gassin M, Gueudin M, Halfon P, Larrat S, Lunel F, Martinot-Peignoux M, Mercier B, Pawlotsky JM, Pozzetto B, Roque-Afonso AM, Roudot-Thoraval F, Sauné K, Lefrère JJ. Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol 2006;44:3600-7. [PMID: 17021089 DOI: 10.1128/JCM.00732-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
34 Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis. 2013;56:1704-1712. [PMID: 23487379 DOI: 10.1093/cid/cit166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
35 Martinez RM, Wolk DM. Bloodstream Infections. In: Hayden RT, Wolk DM, Carroll KC, Tang Y, editors. Diagnostic Microbiology of the Immunocompromised Host. Washington: ASM Press; 2016. pp. 653-89. [DOI: 10.1128/9781555819040.ch25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Petrik J. Microarray blood testing: Pros & cons. Biologicals 2010;38:2-8. [DOI: 10.1016/j.biologicals.2009.10.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
37 Seed CR. Value of retaining HBsAg donor screening where HBV NAT and anti-HBc donor screening apply. VOXS 2018;13:70-5. [DOI: 10.1111/voxs.12368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Calabrese LH, Zein NN, Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis. 2006;65:983-989. [PMID: 16627542 DOI: 10.1136/ard.2005.043257] [Cited by in Crossref: 150] [Cited by in F6Publishing: 117] [Article Influence: 10.0] [Reference Citation Analysis]
39 . Effectiveness of various minipool nucleic acid test systems for hepatitis B virus detection in blood donors. Transfusion 2009;49:1494-5. [DOI: 10.1111/j.1537-2995.2009.02225.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Beltrán M, Berrío-pérez M, Bermúdez MI, Rey-benito G, Camacho B, Forero P, Molina GC, Fals O, Pisciotti I, Oliveros Y, Cortés A, De La Hoz F. Detección de hepatitis B oculta en donantes de bancos sangre, Colombia 2008-2009. biomedica 2011;31:580. [DOI: 10.7705/biomedica.v31i4.446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Miletić M, Bingulac-Popović J, Stojić Vidović M, Hećimović A, Berendika M, Babić I, Đogić V, Samardžija M, Barišić K, Jukić I, Mihaljević I. Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing. Transfus Clin Biol 2019;26:257-62. [PMID: 31153786 DOI: 10.1016/j.tracli.2019.05.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23-29. [PMID: 19919328 DOI: 10.1515/cclm.2010.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
43 Marzano A. Management of HBV infection during immunosuppressive treatment. Mediterr J Hematol Infect Dis. 2009;1:e2009025. [PMID: 21415959 DOI: 10.4084/mjhid.2009.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
44 Allain JP, Stramer SL, Carneiro-Proietti AB, Martins ML, Lopes da Silva SN, Ribeiro M, Proietti FA, Reesink HW. Transfusion-transmitted infectious diseases. Biologicals. 2009;37:71-77. [PMID: 19231236 DOI: 10.1016/j.biologicals.2009.01.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 8.0] [Reference Citation Analysis]
45 Rodríguez-frias F, Jardi R. Virología molecular del virus de la hepatitis B. Enfermedades Infecciosas y Microbiología Clínica 2008;26:2-10. [DOI: 10.1016/s0213-005x(08)76514-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
46 Kuhns MC, Busch MP. New Strategies for Blood Donor Screening for Hepatitis B Virus: Nucleic Acid Testing versus Immunoassay Methods. Mol Diag Ther 2006;10:77-91. [DOI: 10.1007/bf03256447] [Cited by in Crossref: 64] [Cited by in F6Publishing: 18] [Article Influence: 7.1] [Reference Citation Analysis]
47 Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology. 2006;44:1666-1674. [PMID: 17133474 DOI: 10.1002/hep.21413] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 5.7] [Reference Citation Analysis]
48 Pinna D, Sampson-Johannes A, Clementi M, Poli G, Rossini S, Lin L, Vicenzi E. Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates. Transfus Med 2005;15:269-76. [PMID: 16101804 DOI: 10.1111/j.0958-7578.2005.00588.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
49 Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 2007;40:255-8. [PMID: 17869170 DOI: 10.1016/j.jcv.2007.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
50 Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007;14:16-21. [DOI: 10.1111/j.1365-2893.2007.00912.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
51 Chen H, Su T, Tseng T, Yang W, Chen T, Chen P, Chen D, Kao J, Liu C. Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up. Journal of the Formosan Medical Association 2017;116:697-704. [DOI: 10.1016/j.jfma.2016.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Zhu HL, Li X, Li J, Zhang ZH. Genetic variation of occult hepatitis B virus infection. World J Gastroenterol. 2016;22:3531-3546. [PMID: 27053845 DOI: 10.3748/wjg.v22.i13.3531] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
53 Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection. 2009;37:445-449. [PMID: 19669092 DOI: 10.1007/s15010-008-8194-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
54 Goral V, Ozkul H, Tekes S, Sit D, Kadiroglu AK. Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J Gastroenterol. 2006;12:3420-3424. [PMID: 16733862 DOI: 10.3748/wjg.v12.i21.3420] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
55 Wang J, Zhang P, Zeng J, Du P, Zheng X, Ye X, Zhu W, Fu Y, Candotti D, Allain JP, Li C, Li T. Occurrence of occult hepatitis B virus infection associated with envelope protein mutations according to anti-HBs carriage in blood donors. Int J Infect Dis 2020;92:38-45. [PMID: 31877352 DOI: 10.1016/j.ijid.2019.12.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Louisirirotchanakul S, Oota S, Khuponsarb K, Chalermchan W, Phikulsod S, Chongkolwatana V, Sakuldamrongpanish T, Kitpoka P, Chielsilp P, Tanprasert S, Tirawatnapong T, Wasi C; Working Group for NAT Study in Thai Blood Donations. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40. [PMID: 21251005 DOI: 10.1111/j.1537-2995.2010.03023.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
57 Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion. 2013;53:1393-1404. [PMID: 23033944 DOI: 10.1111/j.1537-2995.2012.03909.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
58 Larralde O, Dow B, Jarvis L, Davidson F, Petrik J. Hepatitis B escape mutants in Scottish blood donors. Med Microbiol Immunol. 2013;202:207-214. [PMID: 23274404 DOI: 10.1007/s00430-012-0283-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
59 Mahgoub S, Candotti D, El Ekiaby M, Allain JP. Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol 2011;49:298-306. [PMID: 21048009 DOI: 10.1128/JCM.00867-10] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
60 Yaseen SG, Ahmed SA, Johan MF, Kiron R, Daher AM. Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors. Transfus Apher Sci 2013;49:647-51. [PMID: 23890575 DOI: 10.1016/j.transci.2013.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
61 Darmawan E, Turyadi KE, Nursanty NK, Thedja MD, Muljono DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol. 2015;87:199-207. [PMID: 25521058 DOI: 10.1002/jmv.24045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
62 Dineva MA, MahiLum-Tapay L, Lee H. Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings. Analyst 2007;132:1193-9. [PMID: 18318279 DOI: 10.1039/b705672a] [Cited by in Crossref: 112] [Cited by in F6Publishing: 100] [Article Influence: 8.6] [Reference Citation Analysis]
63 Khorami F, Sobhani SA, Davoudian P, Khajeh E. Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran. Electron Physician 2013;5:659-63. [PMID: 26120400 DOI: 10.14661/2013.659-663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Martin LA, Stramer SL, Kuhns MC, Schlauder GG. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations: CORRELATE HBsAg DETECTION LIMIT WITH NAT. Transfusion 2012;52:2201-8. [DOI: 10.1111/j.1537-2995.2011.03553.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
65 Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008;46:868-875. [PMID: 18269332 DOI: 10.1086/528687] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
66 Romero M, Madejón A, Fernández-Rodríguez C, García-Samaniego J. Clinical significance of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1549-1552. [PMID: 21472119 DOI: 10.3748/wjg.v17.i12.1549] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
67 Kumari S. Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study. Indian J Sex Transm Dis AIDS 2020;41:22-9. [PMID: 33062977 DOI: 10.4103/0253-7184.196887] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Yao QQ, Dong XL, Wang XC, Ge SX, Hu AQ, Liu HY, Wang YA, Yuan Q, Zheng YJ. Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination. Clin Vaccine Immunol. 2013;20:269-275. [PMID: 23254298 DOI: 10.1128/cvi.00539-12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Su WJ, Ho MC, Ni YH, Wu JF, Jeng YM, Chen HL, Wu YM, Hu RH, Chang MH, Lee PH. Clinical course of de novo hepatitis B infection after pediatric liver transplantation. Liver Transpl. 2010;16:215-221. [PMID: 20104496 DOI: 10.1002/lt.21980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
70 Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009;49:2454-2489. [PMID: 19682345 DOI: 10.1111/j.1537-2995.2009.02322.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 142] [Article Influence: 12.9] [Reference Citation Analysis]
71 Yildiz UH, Inci F, Wang S, Toy M, Tekin HC, Javaid A, Lau DT, Demirci U. Recent advances in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol Adv 2015;33:178-90. [PMID: 25450190 DOI: 10.1016/j.biotechadv.2014.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
72 Allain J. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening. Vox Sang 2007;92:254-7. [DOI: 10.1111/j.1423-0410.2006.00874.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
73 Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008;48:2205-2213. [PMID: 18631163 DOI: 10.1111/j.1537-2995.2008.01813.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
74 Zanetti AR, Romanò L, Zappá A, Velati C. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. Journal of Clinical Virology 2006;36:S51-5. [DOI: 10.1016/s1386-6532(06)80009-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
75 Iudicone P, Miceli M, Palange M, Agresti A, Gallo A, Isacchi G, Girolami E, Pierelli L, Mannella E. Hepatitis B virus blood screening: impact of nucleic amplification technology testing implementation on identifying hepatitis B surface antigen non-reactive window period and chronic infections. Vox Sanguinis 2009;96:292-7. [DOI: 10.1111/j.1423-0410.2009.01171.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
76 Ks M, R A, P A. The prevalence of the hepatitis B core antibody and the occult hepatitis B infection among voluntary blood donors in chennai, India. J Clin Diagn Res. 2012;6:1710-1712. [PMID: 23373034 DOI: 10.7860/jcdr/2012/4826.2636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol 2016;3:e000067. [PMID: 26966550 DOI: 10.1136/bmjgast-2015-000067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Panhotra BR, Hassan ZU, Joshi CS, Bahrani A. Visual detection of multiple viral amplicons by dipstick assay: its application in screening of blood donors a welcome tool for the limited resource settings. J Clin Microbiol 2005;43:6218; author reply 6218-9. [PMID: 16333138 DOI: 10.1128/JCM.43.12.6218-6219.2005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
79 Herbrecht R, Ojeda-uribe M, Kientz D, Fohrer C, Bohbot A, Hinschberger O, Liu K, Remy E, Ernst C, Lin J, Corash L, Cazenave JP. Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura. Vox Sang 2018;113:459-67. [DOI: 10.1111/vox.12663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
80 Zaaijer HL, Torres P, Ontañón A, Ponte LG, Koppelman MH, Lelie PN, Hemert FJ, Boot HJ. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection. J Med Virol 2008;80:1344-9. [PMID: 18551607 DOI: 10.1002/jmv.21233] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
81 Dhawan HK, Marwaha N, Sharma RR, Chawla Y, Thakral B, Saluja K, Sharma SK, Thakur MK, Jain A. Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol 2008;14:5327-30. [PMID: 18785287 DOI: 10.3748/wjg.14.5327] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
82 Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J 2011;8:513. [PMID: 22074048 DOI: 10.1186/1743-422X-8-513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
83 Samardžija M, Drenjančević D, Miletić M, Slavulj B, Jukić I, Zibar L, Mihaljević S, Ferenac Kiš M, Samardžija M. THE IMPACT OF POSITIVE ANTI-HBC MARKER ON PERMANENT DEFERRAL OF VOLUNTARY BLOOD DONORS IN EASTERN CROATIA AND ESTIMATION OF OCCULT HEPATITIS B VIRUS INFECTION RATE. Acta Clin Croat 2020;59:126-34. [PMID: 32724283 DOI: 10.20471/acc.2020.59.01.15] [Reference Citation Analysis]
84 Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol 2007;14:671-6. [PMID: 17898573 DOI: 10.1097/MOH.0b013e3282e38e8a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 23] [Article Influence: 0.1] [Reference Citation Analysis]
85 Ha J, Park Y, Kim HS. Evaluation of clinical sensitivity and specificity of hepatitis B virus (HBV), hepatitis C virus, and human immunodeficiency Virus-1 by cobas MPX: Detection of occult HBV infection in an HBV-endemic area. J Clin Virol 2017;96:60-3. [PMID: 28982042 DOI: 10.1016/j.jcv.2017.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Benjamin RJ. Bacterial detection in platelet components and the rationale for pathogen inactivation: A blood center perspective. J Clin Apheresis 2005;20:117-22. [DOI: 10.1002/jca.20041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
87 Nishiya AS, Levi JE, de Almeida-Neto C, Witkin SS, Ferreira SC, Bassit L, Sabino EC, Di-Lorenzo-Oliveira C, Salles NA, Coutinho AS, Bellesa MA, Rocha V, Mendrone-Jr A. Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil. Transfusion 2021;61:1495-504. [PMID: 33687074 DOI: 10.1111/trf.16344] [Reference Citation Analysis]
88 Candotti D, El Chaar M, Allain J. Transfusion transmission of hepatitis B virus: still learning more about it: Transfusion transmission of hepatitis B virus. ISBT Science Series 2011;6:234-40. [DOI: 10.1111/j.1751-2824.2011.01493.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
89 Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci 2007;1:62-70. [PMID: 21938236 DOI: 10.4103/0973-6247.33445] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
90 Villalba R, Fornés G, Eisman M, Gómez Villagrán JL. Evaluation of tissue discards after implementation of anti-HBc test in a tissue bank in Spain. Cell Tissue Bank 2007;8:303-5. [PMID: 17447156 DOI: 10.1007/s10561-007-9039-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
91 Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H; Japanese Red Cross NAT Screening Research Group. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007;47:1162-71. [PMID: 17581150 DOI: 10.1111/j.1537-2995.2007.01234.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
92 Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich WH, Glebe D. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion. 2009;49:1621-1629. [PMID: 19413737 DOI: 10.1111/j.1537-2995.2009.02188.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
93 Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion. 2011;51:1840-1846. [PMID: 21332731 DOI: 10.1111/j.1537-2995.2010.03056.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
94 Inaba S, Ito A, Miyata Y, Ishii H, Kajimoto S, Tanaka M, Maruta A, Saito S, Yugi H, Hino M. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion. 2006;46:2028-2029. [PMID: 17076860 DOI: 10.1111/j.1537-2995.2006.01011.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
95 Yang Z, Xu L, Liu L, Feng Q, Zhang L, Ma W, Saldanha J, Wang M, Zhao L. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2: NAT screening of blood donors in China. Transfusion 2013;53:2538-44. [DOI: 10.1111/trf.12159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
96 Kishk R, Nemr N, Elkady A, Mandour M, Aboelmagd M, Ramsis N, Hassan M, Soliman N, Iijima S, Murakami S, Tanaka Y, Ragheb M. Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt. Virol J 2015;12:153. [PMID: 26420301 DOI: 10.1186/s12985-015-0389-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
97 Weber B. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene. Expert Rev Mol Diagn. 2005;5:75-91. [PMID: 15723594 DOI: 10.1586/14737159.5.1.75] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
98 Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. BMC Cancer. 2012;12:452. [PMID: 23039099 DOI: 10.1186/1471-2407-12-452] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
99 Thedja MD, Roni M, Harahap AR, Siregar NC, Ie SI, Muljono DH. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int. 2010;4:608-614. [PMID: 21063484 DOI: 10.1007/s12072-010-9203-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
100 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
101 Staginnus U, Corash L. Economics of Pathogen Inactivation Technology for Platelet Concentrates in Japan. International Journal of Hematology 2004;80:317-24. [DOI: 10.1532/ijh97.04131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
102 Fang CT. Blood screening for HBV DNA. J Clin Virol 2006;36 Suppl 1:S30-2. [PMID: 16831691 DOI: 10.1016/s1386-6532(06)80006-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
103 Safic Stanic H, Babic I, Maslovic M, Dogic V, Bingulac-Popovic J, Miletic M, Jurakovic-Loncar N, Vuk T, Strauss-Patko M, Jukic I. Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia. Transfus Med Hemother 2017;44:415-20. [PMID: 29344018 DOI: 10.1159/000457965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
104 Panhotra B, Bahrani A, Joshi C, Hassan ZU. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT. Journal of Infection 2005;51:263. [DOI: 10.1016/j.jinf.2005.07.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
105 de la Fuente RA, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol. 2011;17:1543-1548. [PMID: 21472118 DOI: 10.3748/wjg.v17.i12.1543] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
106 Li L, Han T, Zang L, Niu L, Cheng W, Lin H, Li KY, Cao R, Zhao B, Liu Y, Ou G, Liu X, Qi Y, Li Y, Liu Z. The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China. BMC Infect Dis 2017;17:754. [PMID: 29212443 DOI: 10.1186/s12879-017-2861-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
107 Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP. Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol. 2008;89:409-418. [PMID: 18198371 DOI: 10.1099/vir.0.83347-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
108 Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen: ANTI-HBc TESTING OF BLOOD DONORS. Transfusion 2011;51:1477-85. [DOI: 10.1111/j.1537-2995.2010.03031.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
109 Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol 2011;17:1563-8. [PMID: 21472122 DOI: 10.3748/wjg.v17.i12.1563] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
110 Chamni N, Louisirirotchanakul S, Oota S, Sakuldamrongpanish T, Saldanha J, Chongkolwatana V, Phikulsod S. Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection. Vox Sang. 2014;107:324-332. [PMID: 25040474 DOI: 10.1111/vox.12178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
111 Allain J, Sarkodie F, Candotti D, Opare-sem O. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion 2005;45:1039-40. [DOI: 10.1111/j.1537-2995.2005.00473.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
112 Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-10. [PMID: 19656713 DOI: 10.1016/j.ijid.2009.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
113 Daniel HD, Fletcher JG, Chandy GM, Abraham P. Quantitation of hepatitis B virus DNA in plasma using a sensitive cost-effective “in-house” real-time PCR assay. Indian J Med Microbiol. 2009;27:111-115. [PMID: 19384032 DOI: 10.4103/0255-0857.45362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
114 Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E. HBsAg non-reactive HBV infection in blood donors: Transmission and pathogenicity. J Med Virol 2007;79:S32-6. [DOI: 10.1002/jmv.20963] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
115 Tani Y, Aso H, Matsukura H, Tadokoro K, Tamori A, Nishiguchi S, Yoshizawa H, Shibata H. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections. Vox Sang. 2012;102:285-293. [PMID: 22082342 DOI: 10.1111/j.1423-0410.2011.01561.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
116 El-Ghitany EM, Farghaly AG, Hashish MH. Occult hepatitis B virus infection among hepatitis C virus seropositive and seronegative blood donors in Alexandria, Egypt. J Egypt Public Health Assoc. 2013;88:8-13. [PMID: 23528526 DOI: 10.1097/01.epx.0000422774.29308.b3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
117 Kiely P, Margaritis AR, Seed CR, Yang H. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Transfusion. 2014;54:2084-2091. [PMID: 24650170 DOI: 10.1111/trf.12556] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
118 Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007;47:74-79. [PMID: 17207233 DOI: 10.1111/j.1537-2995.2007.01066.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
119 Lanini S, Puro V, Lauria FN, Fusco FM, Nisii C, Ippolito G. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med. 2009;7:15. [PMID: 19356228 DOI: 10.1186/1741-7015-7-15] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
120 Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Phikulsod S, Oota S, Lin M, Saldanha J, Kleinman SH. Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield: HBV TRIPLEX NAT COMPARISONS. Transfusion 2011;51:2012-22. [DOI: 10.1111/j.1537-2995.2011.03140.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
121 Hu XB, Yue QH, Zhang XQ, Xu XQ, Wen Y, Chen YZ, Cheng XD, Yang L, Mu SJ. Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China. Virol J 2009;6:199. [PMID: 19917138 DOI: 10.1186/1743-422X-6-199] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
122 Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine 2012;30:4034-9. [PMID: 22531558 DOI: 10.1016/j.vaccine.2012.04.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
123 Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? Lancet. 2005;365:638-640. [PMID: 15721459 DOI: 10.1016/s0140-6736(05)17961-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
124 Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010;17:1-15. [PMID: 20002296 DOI: 10.1111/j.1365-2893.2009.01245.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
125 Allain J, Belkhiri D, Vermeulen M, Crookes R, Cable R, Amiri A, Reddy R, Bird A, Candotti D. Characterization of occult hepatitis B virus strains in south african blood donors. Hepatology 2009;49:1868-76. [DOI: 10.1002/hep.22879] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
126 Rios J, Hambleton J, Viele M, Rugg N, Sindermann G, Greenwalt T, Wages D, Cook D, Corash L. Viability of red cells prepared with S-303 pathogen inactivation treatment. Transfusion 2006;46:1778-86. [DOI: 10.1111/j.1537-2995.2006.00973.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
127 Wang Q, Klenerman P, Semmo N. Significance of anti-HBc alone serological status in clinical practice. The Lancet Gastroenterology & Hepatology 2017;2:123-34. [DOI: 10.1016/s2468-1253(16)30076-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 5.3] [Reference Citation Analysis]
128 Hatzakis A, Magiorkinis E, Haida C. HBV virological assessment. J Hepatol. 2006;44:S71-S76. [PMID: 16343681 DOI: 10.1016/j.jhep.2005.11.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
129 Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus 2017;15:6-12. [PMID: 27416568 DOI: 10.2450/2016.0268-15] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
130 Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect. 2007;54:185-191. [PMID: 16564573 DOI: 10.1016/j.jinf.2006.02.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
131 Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Transfusion 2006;46:2047-52. [PMID: 17176315 DOI: 10.1111/j.1537-2995.2006.01031.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
132 Bielawski KP, Stalke P. Molecular epidemiology of chronic hepatitis B virus infection in northern Poland. J Clin Virol. 2005;34 Suppl 1:S63-S69. [PMID: 16461226 DOI: 10.1016/s1386-6532(05)80012-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
133 Ye X, Yang B, Zhu W, Zheng X, Du P, Zeng J, Li C. Six-year pilot study on nucleic acid testing for blood donations in China. Transfus Apher Sci 2013;49:318-22. [PMID: 24007868 DOI: 10.1016/j.transci.2013.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
134 Seed CR, Kiely P. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening. Vox Sang 2013;105:290-8. [DOI: 10.1111/vox.12060] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
135 Dineva MA, Candotti D, Fletcher-Brown F, Allain JP, Lee H. Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 2005;43:4015-21. [PMID: 16081944 DOI: 10.1128/JCM.43.8.4015-4021.2005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
136 Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20:426-439, table of contents. [PMID: 17630333 DOI: 10.1128/cmr.00009-07] [Cited by in Crossref: 86] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
137 Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1927-1938. [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
138 Lavanchy D, Kane M. Global Epidemiology of Hepatitis B Virus Infection. In: Liaw Y, Zoulim F, editors. Hepatitis B Virus in Human Diseases. Cham: Springer International Publishing; 2016. pp. 187-203. [DOI: 10.1007/978-3-319-22330-8_9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 5.6] [Reference Citation Analysis]
139 Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, Patnaik B, Chakrabarti S, Chakravarty R. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010;7:204. [PMID: 20799931 DOI: 10.1186/1743-422x-7-204] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
140 Stratta P, Bruschetta E, Minisini R, Barbè MC, Cornella C, Tognarelli G, Cena T, Magnani C, Fenoglio R, Toffolo K, Airoldi A, Pirisi M. Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation. Transplant Proc 2009;41:1132-7. [PMID: 19460498 DOI: 10.1016/j.transproceed.2009.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
141 Martinez RM, Wolk DM. Bloodstream Infections. Microbiol Spectr 2016;4. [PMID: 27726765 DOI: 10.1128/microbiolspec.DMIH2-0031-2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
142 Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008;48:1198-206. [PMID: 18422856 DOI: 10.1111/j.1537-2995.2008.01672.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
143 Wang Q, Sachse P, Semmo M, Lokhande M, Montani M, Dufour JF, Zoulim F, Klenerman P, Semmo N. T- and B-cell responses and previous exposure to hepatitis B virus in ‘anti-HBc alone’ patients. J Viral Hepat. 2015;22:1068-1078. [PMID: 26075501 DOI: 10.1111/jvh.12428] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
144 Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015;7:600-6. [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
145 Ba Alawi F, Robertson PW, LePage AK, Jayamaha J, Baleriola C, Rawlinson WD. The reliability of HBV core antibody in serological screening for hepatitis B virus. Pathology 2013;45:501-5. [PMID: 23842045 DOI: 10.1097/PAT.0b013e3283631cf9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
146 Stolz M, Tinguely C, Fontana S, Niederhauser C. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors: Sensitivity Limit for HBV DNA in Blood Donors. Transfusion 2014;54:2961-7. [DOI: 10.1111/trf.12694] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
147 da Costa CA, Kimura LO. Molecular epidemiology of hepatitis B virus among the indigenous population of the Curuçá and Itaquaí Rivers, Javari Valley, State of Amazonas, Brazil. Rev Soc Bras Med Trop 2012;45:457-62. [PMID: 22930043 DOI: 10.1590/s0037-86822012000400008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
148 Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD, Ma HL, Zhou ZM, Bi XH, Tu L, King M, Nelson K, Ness P, Shan H. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion 2011;51:2588-95. [PMID: 21682731 DOI: 10.1111/j.1537-2995.2011.03215.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
149 Yugi H, Mizui M, Tanaka J, Yoshizawa H. Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. J Clin Virol 2006;36 Suppl 1:S56-64. [PMID: 16831695 DOI: 10.1016/s1386-6532(06)80010-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
150 Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46:160-170. [PMID: 17112622 DOI: 10.1016/j.jhep.2006.10.007] [Cited by in Crossref: 335] [Cited by in F6Publishing: 318] [Article Influence: 22.3] [Reference Citation Analysis]
151 Schmidt M, Jimenez A, Mühlbacher A, Oota S, Blanco L, Sakuldamrongpanich T, Schennach H, Seifried E. Head-to-head comparison between two screening systems for HBsAG, anti-HBc, anti-HCV and HIV combination immunoassays in an international, multicentre evaluation study. Vox Sang 2015;109:114-21. [PMID: 25899479 DOI: 10.1111/vox.12259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
152 Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion. 2007;47:1197-1205. [PMID: 17581154 DOI: 10.1111/j.1537-2995.2007.01276.x] [Cited by in Crossref: 146] [Cited by in F6Publishing: 139] [Article Influence: 10.4] [Reference Citation Analysis]
153 Allice T, Cerutti F, Pittaluga F, Varetto S, Gabella S, Marzano A, Franchello A, Colucci G, Ghisetti V. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol. 2007;45:828-834. [PMID: 17229858 DOI: 10.1128/jcm.00914-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
154 Chen J, Liu B, Tang X, Zheng X, Lu J, Zhang L, Wang W, Candotti D, Fu Y, Allain JP, Li C, Li L, Li T. Role of core protein mutations in the development of occult HBV infection. J Hepatol 2021;74:1303-14. [PMID: 33453326 DOI: 10.1016/j.jhep.2020.12.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005;45:580-90. [PMID: 15819680 DOI: 10.1111/j.0041-1132.2005.04316.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 7.6] [Reference Citation Analysis]
156 Kumar H, Gupta PK, Jaiprakash M. The Role of anti-HBc IgM in Screening of Blood Donors. Med J Armed Forces India 2007;63:350-2. [PMID: 27408047 DOI: 10.1016/S0377-1237(07)80013-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
157 Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48:743-746. [PMID: 18314221 DOI: 10.1016/j.jhep.2008.01.023] [Cited by in Crossref: 129] [Cited by in F6Publishing: 129] [Article Influence: 9.9] [Reference Citation Analysis]
158 Shaha M, Hoque SA, Ahmed MF, Rahman SR. Effects of Risk Factors on Anti-HBs Development in Hepatitis B Vaccinated and Nonvaccinated Populations. Viral Immunol 2015;28:217-21. [PMID: 25714135 DOI: 10.1089/vim.2014.0147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
159 Satoh K, Iwata-Takakura A, Yoshikawa A, Gotanda Y, Tanaka T, Yamaguchi T, Mizoguchi H. A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection. Vox Sang. 2008;95:174-180. [PMID: 19121181 DOI: 10.1111/j.1423-0410.2008.01091.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
160 De Brier N, Koc ÖM, De Buck E, Muylaert A, Nevens F, Vanbrabant M, Vandeloo J, Van Remoortel H, Robaeys G, Compernolle V. Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migration. Transfusion 2021;61:2125-36. [PMID: 33955570 DOI: 10.1111/trf.16431] [Reference Citation Analysis]
161 Niederhauser C, Weingand T, Candotti D, Maier A, Tinguely C, Wuillemin WA, Gowland P, Allain JP, Stolz M. Fatal outcome of a hepatitis B virus transfusion-transmitted infection. Vox Sang 2010;98:504-7. [PMID: 20070649 DOI: 10.1111/j.1423-0410.2009.01304.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
162 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
163 Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C; Working Group for NAT Study in Thai Blood Donations. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009;49:1126-35. [PMID: 19392770 DOI: 10.1111/j.1537-2995.2009.02176.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
164 Ohhashi Y, Pai A, Halait H, Ziermann R. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system. Journal of Virological Methods 2010;165:246-53. [DOI: 10.1016/j.jviromet.2010.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
165 Zhang M, Ge G, Yang Y, Cai X, Fu Q, Cai J, Huang Z. Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants. Virol J 2013;10:292. [PMID: 24053482 DOI: 10.1186/1743-422X-10-292] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
166 Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798-809. [PMID: 19615780 DOI: 10.1016/j.jhep.2009.05.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 9.6] [Reference Citation Analysis]
167 Mohamud HS, Mohamed DH, Alqahtani FH, Almajid FM, Alswat K, Somily AM. Two years' experience of implementing molecular screening of hepatitis B virus, hepatitis C virus and human immunodeficiency virus 1, 2 in Riyadh blood donors. Transfus Apher Sci 2016;54:262-5. [PMID: 26497616 DOI: 10.1016/j.transci.2015.10.003] [Reference Citation Analysis]
168 Seed CR, Maloney R, Kiely P, Bell B, Keller AJ, Pink J; the Blood Service Medical Services Lookback Team. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme. Vox Sang 2015;108:113-22. [DOI: 10.1111/vox.12198] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
169 Prati D, Gerosa A, Porretti L. Occult HBV infection and blood transfusion. J Hepatol. 2006;44:818; author reply 819. [PMID: 16473431 DOI: 10.1016/j.jhep.2005.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
170 Allain J, Lee H. Rapid tests for detection of viral markers in blood transfusion. Expert Review of Molecular Diagnostics 2014;5:31-41. [DOI: 10.1586/14737159.5.1.31] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
171 Takizawa K, Nakashima T, Mizukami T, Kuramitsu M, Endoh D, Kawauchi S, Sasaki K, Momose H, Kiba Y, Mizutani T, Furuta RA, Yamaguchi K, Hamaguchi I. Degenerate polymerase chain reaction strategy with DNA microarray for detection of multiple and various subtypes of virus during blood screening. Transfusion 2013;53:2545-55. [PMID: 23590180 DOI: 10.1111/trf.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
172 Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR. High levels of serum hepatitis B virus DNA in patients with ‘anti-HBc alone’: role of HBsAg mutants. J Viral Hepat. 2011;18:721-729. [PMID: 21914087 DOI: 10.1111/j.1365-2893.2011.01482.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
173 Enjalbert F, Krysztof DE, Candotti D, Allain J, Stramer SL. Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors: Nat of low-level hbv dna-positive samples. Transfusion 2014;54:2485-95. [DOI: 10.1111/trf.12653] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
174 Chaurasia R, Rout D, Zaman S, Chatterjee K, Pandey HC, Maurya AK. Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India. Int J Microbiol 2016;2016:2543156. [PMID: 26904124 DOI: 10.1155/2016/2543156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
175 Leung VKS, Lee CK, Chau TN, Cheung WI, Lo FH, Lai KB, Lin CK. A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. Transfusion Medicine 2010;20:276-7. [DOI: 10.1111/j.1365-3148.2010.00997.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
176 Said ZN, Sayed MH, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol. 2013;5:64-73. [PMID: 23646231 DOI: 10.4254/wjh.v5.i2.64] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
177 Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M, Reddy R, Crookes R, Kramvis A. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion. 2012;52:880-892. [PMID: 21981386 DOI: 10.1111/j.1537-2995.2011.03355.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
178 Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong Y, Nichols D, Ziermann R, Ness P, Nelson KE. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand: MULTIPLEX NAT SCREENING IN THAILAND. Transfusion 2007;47:1803-8. [DOI: 10.1111/j.1537-2995.2007.01395.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
179 Allain J. Occult hepatitis B virus infection and transfusion. Journal of Hepatology 2006;44:617-8. [DOI: 10.1016/j.jhep.2005.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
180 María García-montalvo B, Patricia Ventura-zapata L. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Annals of Hepatology 2011;10:133-41. [DOI: 10.1016/s1665-2681(19)31561-3] [Cited by in Crossref: 14] [Article Influence: 1.4] [Reference Citation Analysis]
181 Lavanchy D. Hepatitis B Virus Transmission in Organ, Tissue, and Cell Transplantation. Gastroenterology 2008;135:1041-3. [DOI: 10.1053/j.gastro.2008.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
182 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
183 Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang. 2006;91:1-12. [PMID: 16756595 DOI: 10.1111/j.1423-0410.2006.00773.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]